CliffBio
small molecule

INFANT'S ADVIL

IBUPROFEN

Loss of exclusivity—loss of exclusivity
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand nameINFANT'S ADVIL
Active ingredientIBUPROFEN
Strength50MG/1.25ML
Dosage formSUSPENSION/DROPS
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2000
Marketing statusOTC

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.